Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannTrust Holdings Inc CNTTQ

CannTrust Holdings Inc is engaged in the business of producing and distributing medical cannabis in Canada. Its facility is located at Vaughan, Ontario in Canada. Its brands include LIIV, ESCAPE, SYNR.G and Peak Leaf.


GREY:CNTTQ - Post by User

Bullboard Posts
Comment by Invest4Life2016on Mar 12, 2018 6:52pm
54 Views
Post# 27703600

RE:RE:RE:RE:CannTrust Is In The Best Position For Multiple Gains

RE:RE:RE:RE:CannTrust Is In The Best Position For Multiple GainsI’m not concerned with their recreational plans, since they’ll be growing in 430,000 sq ft by this May and have enough land at their Niagara lot to build an additional 570,000 sq ft.  They’re already growing out of their 250,000 sq ft facility - 10 batch harvests with very good results since completion.  Plus they’ll be growing in another 180,000 sq ft come this May.   By June/July they’ll be ramped up to produce at the minimum 43,000kg/yr - only WEED will producing more than TRST come rec legalization.  In other words there’s going to be a marijuana shortage this year, so look for the provinces and companies to pick up the pace securing supply contracts real soon.  With TRST’s early large production, I have no doubt that they’re already working on at least one supply contract.  

Come mid 2019 there will be an oversupply in the market if the majority of LPs meet their production targets.  By then TRST’s supply contracts will be in place, while many other LPs will be sitting on a large amount of product.  

Come mid 2019 or earlier, I wouldn’t be surprised to see a drug development with Apotex, leading them to strengthen their partnership to joint develop the additional 570,000 sq ft growing facility in order to produce cannabis products for Apotex’s international business that spans over 115 countries.  CannTrust and Apotex have a significant amount of potential to greatly increase their bottom line in the next couple of years. 





Bullboard Posts